Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_assertion type Assertion NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_head.
- NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_assertion description "[Accumulating data have now identified specific genes that are commonly hypermethylated and inactivated during prostate cancer progression, including GSTpi, APC, MDR1, GPX3 and 14-3-3sigma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_provenance.
- NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_assertion evidence source_evidence_literature NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_provenance.
- NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_assertion SIO_000772 17296351 NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_provenance.
- NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_assertion wasDerivedFrom befree-2016 NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_provenance.
- NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_assertion wasGeneratedBy ECO_0000203 NP593489.RA2ySBsFGA226WiODie56EZgZJL1_92X-wjTmG8ECJc-g130_provenance.